As the COVID-19 pandemic spreads across the world, countries are rushing to put in place strategies to ease the burden on health systems and to mitigate disruption in routine health services. The current social distancing and stay-at-home measures will make it particularly challenging for tuberculosis (TB) programs to provide the necessary diagnosis, treatment and care for the people and communities affected by TB.

The Stop TB Partnership’s TB REACH launched its Wave 8 round of funding to focus on engaging private providers in the TB response.

The World Health Organization (WHO) Global TB Program released a special edition of its newsletter in commemoration of World TB Day, 24 March.

There is clear urgency for bringing quality and effective tuberculosis (TB) prevention, treatment and care closer to communities. These efforts should entail empowering communities to use innovative community-based TB services, which have been shown to have a high impact and to be cost-effective.

The giant cavity, in a protein that transports nutrients across the cell membrane, is unlike anything researchers have seen before.

Active infection with Mycobacterium tuberculosis (TB) enhances anti-HIV-1 antibody response, which may then lead to the emergence of broadly neutralizing antibodies (bnAbs) that target conserved envelope domains.

Kaiser Family Foundation released an updated version of its fact sheet explaining the U.S. government’s role in addressing the global TB epidemic, including the history of U.S. involvement and funding trends.

As governments around the world struggle to contain spiraling infections and an ever-increasing death toll from COVID-19, it’s worth reflecting on what lessons we can draw from the long and still unfinished fight against tuberculosis – the world’s most deadly infectious disease that kills nearly 1.5 million per year.

As the world grapples with the global pandemic of coronavirus, Doctors Without Borders/Médecins Sans Frontières (MSF) is concerned for vulnerable groups worldwide, like people with tuberculosis (TB), whose lungs are often damaged and immune systems weakened.

Three-month regimen expected to prevent TB in those at highest risk of developing the disease, including people living with HIV and children under the age of five.